Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

Completed · Phase 2

Conditions studied: Parkinson Disease, Parkinsonian Syndrome

In brief

Study participants who have been clinically diagnosed with Parkinson disease will receive no treatment, treatment with either levodopa, or treatment with Mirapex for a period of 12 weeks. Over the course of the study subjects will travel to the Institute for Neurodegenerative Disorders (IND) in New Haven, Connecticut for brain imaging.

Key facts

Study ID
NCT00096720
Run by
Institute for Neurodegenerative Disorders
People needed
112
Starts
2004-02-01
Expected to finish
2007-05-01
Last updated by the study team
2010-09-29

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.